Exhibit 16.1
July 3, 2020
US Securities and Exchange Commission
Office of the Chief Accountant
100 F Street, NE
Washington, DC 20549
Re: Avita Therapeutics, Inc.
File No. 001-39059
Dear Sir or Madam:
We have read Item 4.01 of Form 8-K of Avita Therapeutics Inc. dated July 6, 2020 and agree with the statements concerning our Firm contained therein.
Very truly yours,
| /s/ GRANT THORNTON AUDIT PTY LTD |
| Sydney, NSW Australia |
| July 3, 2020 |
